Consolidated statement of other comprehensive income
| 12 months ended 31.12.2021 |
12 months ended 31.12.2020 |
|
| Net profit for the period | 176,298 | 733,095 |
| Other comprehensive income | ||
| Items that may be reclassified subsequently to profit or loss upon fulfilment of certain conditions | (854,322) | 132,361 |
| Measurement of gross financial assets measured at fair value through other comprehensive income | (969,416) | 163,408 |
| Deferred income tax on the valuation of gross financial assets measured through other comprehensive income | 184,189 | (31,047) |
| Measurement of cash flow hedge accounting derivatives | (85,303) | – |
| Deferred income tax on valuation of gross derivatives hedging cash flows | 16,208 | – |
| Items that cannot be reclassified to profit or loss | 2,867 | (1,779) |
| Actuary gross valuation of employee benefits | 3,540 | (2,196) |
| Deferred income tax on actuarial valuation of gross personnel expenses | (673) | 417 |
| Other comprehensive income (net) | (851,455) | 130,582 |
| Total comprehensive income | (675 157) | 863,677 |
| attributable to equity holders of the Group | (675,157) | 863,677 |